Energy logo
Hero background
Empower logo

On a mission to
shape the future of epilepsy patient care and research.

The EMPOWER study is an observational study with the goal of better understanding the collective needs of patients with epilepsy. By participating, you'll receive access to resources that can enhance your understanding of your epilepsy and further empower you in your journey.

For Healthcare Providers

About the EMPOWER study

The EMPOWER study aims to create a secure, comprehensive database of health information from a diverse population of individuals living with epilepsy in the United States, to support ongoing efforts to advance and improve epilepsy treatments.

At Home Participation icon

At Home Participation

You don't need to travel to take part in this study. All activities can take place from the comfort of your home – making it easy to participate wherever you are.

No Cost icon

No Cost

Participation involves no financial cost to you. Study-related resources, such as your consolidated medical records, electronic seizure diary and data summaries are offered at no charge.

Duration icon

Duration

Minimum of 2 years with access
to study resources.

If you are considering joining this study, the first step is to answer a questionnaire about your health and medical history. If you qualify, you can schedule time with one of our clinical trial navigators to hear more about the study.

Share your unique epilepsy experience. See if you or your loved one qualifies.

Why take part?

Empower yourself to play an active role in managing your health

Share Your Epilepsy Journey: Your medical records can help advance understanding of epilepsy and its effects.

Take Control of Your Health: Access all your medical records in one place.

Access Resources: Receive a seizure diary to track your experiences.

Learn From Others With Epilepsy: Gain insights from other living with epilepsy.

If you ever have questions or concerns, you will have a direct contact who you can engage for support at any time.

Your participation is voluntary. You are free to withdraw at any time and for any reason. Your privacy will be maintained throughout the study.

Participation image

Participation requirements
are as followsa:

18 to 75 years old

Has a diagnosis of epilepsy by a healthcare professional

Clinical trial participant

What to expect if I participate

If you qualify and decide to participate, you will receive

Complete the short health questionnaire to see if you prequalify.

Schedule a call with a clinical trial navigator to hear more about the trial and to discuss your health history.

Volunteer your medical records and track your seizure activity.

If you decide to enroll in the study, you'll receive clear instruction on participation and next steps.

Your safety is the highest priority. If you ever have questions or concerns, you can reach out to our team at any time.

About Praxis Precision Medicines

Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating insights from genetic epilepsies into the development of therapies for central nervous system, or CNS, disorders characterized by neuronal excitation-inhibition imbalance.

Frequently asked questions

About EMPOWER

To support ongoing efforts to bring epilepsy treatments to individuals like you, by creating a database of health data which will be available for Praxis researchers to study a broad variety of scientific questions.

Anyone who has a diagnosis of epilepsy by a healthcare provider as defined by the International League Against Epilepsy (ILAE) can participate.

It will take approximately 15 minutes to read the patient informed consent, complete the survey, and if you choose, to share your medical records.

If you have any questions or concerns regarding participating in the Empower study, please email us at info@energyepilepsystudies.com.

No, there is no charge for taking part in this study. The consolidated medical records, electronic seizure diary, data reports are provided for free.

No, there is no compensation for taking part in this study.

The Empower study will run for a minimum of 2 years. At that time, we will evaluate the study and decide whether it will be continued.

Your participation in the study is entirely voluntary and you may withdraw at any time. To withdraw you must let the study team know by writing to the email address info@energyepilepsystudies.com.

Praxis Precision Medicines is the sponsor in conjunction with Epilepsy Study Consortium Inc (ESCI).

In order to ensure that a research study is ethical, and that participants' rights are protected, Institutional Review Boards review and approve study protocols that detail all aspects of how the study is conducted. In addition, study monitors, also known as clinical research associates, confirm that the study protocol procedures and research study requirements and regulations are being followed throughout the study.

Privacy, Costs, and Permissions

Yes, disclosing your health data is completely voluntary.

Access to your data will be strictly limited to authorized personnel involved in the study. We comply with all relevant ethical guidelines and data protection regulations to ensure the security and confidentiality of your information. The results of this research may be published in research reports or scientific publications and presentations. In all such circumstances, Praxis will remove any information that identifies you or reasonably could be used to identify you. The informed consent form will provide more information about how your privacy will be maintained.

Your data will be used exclusively for research purposes.

If you decide to participate, the following personal health data may be collected: 1. Your name, address, telephone number, date of birth, race/ethnicity, medical record numbers, and/or other identifying information 2. Results of examinations, laboratory tests, and procedures, such as physical examinations, blood tests, medical imaging, or other medical procedures 3. Information about your medical conditions and history, health conditions, treatments, and medical procedures, including related dates 4. Sensitive data that may include information about your mental health, use of alcohol/drugs, sexual or infection data, including HIV status